Glaucoma and Possible Risks During SARS-CoV-2 Pandemic
Abstract
Keywords
References
- 1) World Health Organization. Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
- 2) Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; Feb 26 [Epub ahead of print].
- 3) Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE et al. Assessing viral Shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Mar 24. Pii: S0161-6420(20)30311-0.
- 4) Wu P, Duan F, Luo C, Liu Q, Qu, X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020 Mar 31. Doi:10.1001/jamaophthalmol.2020.1291. [Epub ahead of print].
- 5) Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013.
- 6) Li C, Tang Y, Chen Z, Wang A, Huang X, Chen Y, et al. Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19. Chin J Exp Ophthalmol. 2020;38(0):E010.
Details
Primary Language
English
Subjects
Ophthalmology
Journal Section
Letter to Editor
Authors
Mehmet Murat Uzel
*
Türkiye
Publication Date
August 30, 2020
Submission Date
May 8, 2020
Acceptance Date
July 1, 2020
Published in Issue
Year 2020 Volume: 2 Number: 2